Estradiol-Receptor Blockade in Older Men and Women

NCT02271282 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Normal Healthy Volunteers

Interventions

DRUG: Toremifene
DRUG: Placebo
DRUG: GHRH/Ghrelin combined Injection

Sponsor

Mayo Clinic